Temoside (Temozolomide) 250 mg
Temoside 250 (Temozolomide 250 mg) is an alkylating cytotoxic chemotherapy agent, the gold standard treatment for malignant brain tumors.
Manufacturer: Cipla (India). Temoside is a clinically proven generic equivalent of the brand name drug Temodar. Its key unique feature is its ability to easily cross the blood-brain barrier, which most other chemotherapy medications cannot do.
Mechanism of Action:
Temozolomide damages the DNA of cancer cells, preventing them from dividing and replicating, which leads to death of malignant cells.
✅ Key Benefit: Slows tumor growth, extends remission and improves overall survival for patients with brain cancer.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 06.03.2026
What Customers Say
No reviews yet
Your review can be the first!